(Q79426388)

English

Generation and characterization of human monoclonal neutralizing antibodies with distinct binding and sequence features against SARS coronavirus using XenoMouse

scientific article published on 11 December 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17161858%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Generation and characterization of human monoclonal neutralizing antibodies with distinct binding and sequence features against SARS coronavirus using XenoMouse (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17161858%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference

based on heuristic

inferred from title

Osvaldo Martinez

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17161858%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

7

object named as

Michael Farzan

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17161858%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

author name string

Melissa Coughlin

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17161858%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Gin Lou

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17161858%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Stephanie K Masterman

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17161858%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Ole A Olsen

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17161858%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Angelica A Moksa

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17161858%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

John S Babcook

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17161858%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Bellur S Prabhakar

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17161858%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

publication date

11 December 2006

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17161858%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

361

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17161858%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17161858%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

93-102

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17161858%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Coronaviruses: from common colds to severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.029

7 January 2021

Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.029

7 January 2021

Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.029

7 January 2021

Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.029

7 January 2021

SARS: clinical presentation, transmission, pathogenesis and treatment options

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.029

7 January 2021

Use of convalescent plasma therapy in SARS patients in Hong Kong.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.029

7 January 2021

The human immunoglobulin loci introduced into mice: V (D) and J gene segment usage similar to that of adult humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.029

7 January 2021

Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.029

7 January 2021

Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.029

7 January 2021

Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.029

7 January 2021

Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.029

7 January 2021

S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.029

7 January 2021

Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.029

7 January 2021

Structural characterization of the fusion-active complex of severe acute respiratory syndrome (SARS) coronavirus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.029

7 January 2021

Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.029

7 January 2021

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.029

7 January 2021

Structure of SARS coronavirus spike receptor-binding domain complexed with receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.029

7 January 2021

Bats are natural reservoirs of SARS-like coronaviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.029

7 January 2021

Antibody to severe acute respiratory syndrome (SARS)-associated coronavirus spike protein domain 2 cross-reacts with lung epithelial cells and causes cytotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.029

7 January 2021

Human antibodies from transgenic animals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.029

7 January 2021

Oligonucleotide primers for polymerase chain reaction amplification of human immunoglobulin variable genes and design of family-specific oligonucleotide probes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.029

7 January 2021

Severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.029

7 January 2021

Demonstration of an in vivo generated sub-picomolar affinity fully human monoclonal antibody to interleukin-8.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.029

7 January 2021

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.029

7 January 2021

Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.029

7 January 2021

Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.029

7 January 2021

Reshaping a human monoclonal antibody to inhibit human respiratory syncytial virus infection in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.029

7 January 2021

A humanized anti-tumor necrosis factor-alpha monoclonal antibody that acts as a partial, competitive antagonist of the template antibody.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.029

7 January 2021

Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.029

7 January 2021

An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.029

7 January 2021

Structural characterization of the SARS-coronavirus spike S fusion protein core.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.029

7 January 2021

A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.029

7 January 2021

Oligomerization of the SARS-CoV S glycoprotein: dimerization of the N-terminus and trimerization of the ectodomain

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.029

7 January 2021

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.029

7 January 2021

Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.029

7 January 2021

Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.029

7 January 2021

Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.029

7 January 2021

Production of human antibodies from transgenic mice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17161858

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association

1 reference

https://pubmed.ncbi.nlm.nih.gov/17161858

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.VIROL.2006.09.029

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17161858%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

0 references

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17161858%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79426388&oldid=1754245897"